Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models by C. Bastiancich et al.
Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy
in glioblastoma rat models
Submitted by Laurent Lemaire on Wed, 09/12/2018 - 16:20
Titre Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma ratmodels
Type de
publication Article de revue
Auteur
Bastiancich, Chiara [1], Lemaire, Laurent [2], Bianco, John [3], Franconi, Florence
[4], Danhier, Fabienne [5], Préat, Véronique [6], Bastiat, Guillaume [7], Lagarce,
Frédéric [8]
Editeur Future Medicine
Type Article scientifique dans une revue à comité de lecture
Année 2018
Langue Anglais







Mots-clés Glioblastoma [9], Hydrogel [10], Lipid nanocapsules [11], Local delivery [12], MRI[13], rat [14], resection [15]
Résumé en
anglais
AIM: Anticancer drug-loaded hydrogels are a promising strategy for the local
treatment of incurable brain tumors such as glioblastoma (GBM). Recently, we
demonstrated the efficacy of lauroyl-gemcitabine lipid nanocapsule hydrogel
(GemC-LNC) in a U-87 MG xenograft orthotopic mouse model. In this study, we
developed a reliable and reproducible surgical procedure to resect orthotopic GBM
tumors in rats. GemC-LNC hydrogel integrity was tested after brain administration
in rats and its anti-tumor efficacy was tested on a 9L syngeneic orthotopic model.
RESULTS: We demonstrated that LNC integrity is maintained at least for one week
after local administration of GemC-LNC. GemC-LNC was able to delay the
formation of recurrences in 9L tumor-bearing resected rats, demonstrating the
efficacy of this nanomedicine hydrogel in this preclinical model.
CONCLUSION: Our results confirm that GemC-LNC, a hydrogel uniquely formed by
a nanocarrier and a cytotoxic drug, could be a promising and safe delivery tool for
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